Research Areas
Links
Biography and Research Information
OverviewAI-generated summary
Sergio A. Cortés-Ramírez's research focuses on cancer, particularly prostate cancer, and the application of molecular biology techniques. His work has investigated the role of extracellular vesicle-derived microRNAs in prostate cancer metastasis and their association with high-grade Gleason scores, suggesting implications for diagnosis. He has also explored the effects of low-concentration exposure to specific bisphenol compounds on prostate cancer cells through transcriptome-wide analysis. Additionally, his research has examined empirical characterization of false discovery rates in transcriptomic studies using zebrafish embryos. Cortés-Ramírez has co-authored publications with researchers at the University of Arkansas for Medical Sciences, including Alberto Losada-García and Yuet‐Kin Leung. His scholarship metrics include an h-index of 9 with 17 total publications and 238 total citations.
Metrics
- h-index: 9
- Publications: 17
- Citations: 250
Selected Publications
-
Gene Set Enrichment Analysis in Zebrafish Embryos Is Susceptible to False-Positive Results in the Absence of Differentially Expressed Genes (2025)
-
The role of platelets in cancer: from their influence on tumor progression to their potential use in liquid biopsy (2025)
-
Endocrine-Disrupting Chemicals: A Looming Threat to Current and Future Generations (2024)
Collaboration Network
Top Collaborators
- New Approaches in Oncology for Repositioning Drugs: The Case of PDE5 Inhibitor Sildenafil
- Aptamers as Theragnostic Tools in Prostate Cancer
- The role of platelets in cancer: from their influence on tumor progression to their potential use in liquid biopsy
- Hormone-Related Cancer and Autoimmune Diseases: A Complex Interplay to be Discovered
- Unraveling the Role of EV-Derived miR-150-5p in Prostate Cancer Metastasis and Its Association with High-Grade Gleason Scores: Implications for Diagnosis
Showing 5 of 10 shared publications
- New Approaches in Oncology for Repositioning Drugs: The Case of PDE5 Inhibitor Sildenafil
- Aptamers as Theragnostic Tools in Prostate Cancer
- The role of platelets in cancer: from their influence on tumor progression to their potential use in liquid biopsy
- Hormone-Related Cancer and Autoimmune Diseases: A Complex Interplay to be Discovered
- Unraveling the Role of EV-Derived miR-150-5p in Prostate Cancer Metastasis and Its Association with High-Grade Gleason Scores: Implications for Diagnosis
Showing 5 of 9 shared publications
- New Approaches in Oncology for Repositioning Drugs: The Case of PDE5 Inhibitor Sildenafil
- Aptamers as Theragnostic Tools in Prostate Cancer
- The role of platelets in cancer: from their influence on tumor progression to their potential use in liquid biopsy
- Hormone-Related Cancer and Autoimmune Diseases: A Complex Interplay to be Discovered
- Unraveling the Role of EV-Derived miR-150-5p in Prostate Cancer Metastasis and Its Association with High-Grade Gleason Scores: Implications for Diagnosis
Showing 5 of 6 shared publications
- New Approaches in Oncology for Repositioning Drugs: The Case of PDE5 Inhibitor Sildenafil
- Aptamers as Theragnostic Tools in Prostate Cancer
- The role of platelets in cancer: from their influence on tumor progression to their potential use in liquid biopsy
- Hormone-Related Cancer and Autoimmune Diseases: A Complex Interplay to be Discovered
- Unraveling the Role of EV-Derived miR-150-5p in Prostate Cancer Metastasis and Its Association with High-Grade Gleason Scores: Implications for Diagnosis
Showing 5 of 6 shared publications
- New Approaches in Oncology for Repositioning Drugs: The Case of PDE5 Inhibitor Sildenafil
- Aptamers as Theragnostic Tools in Prostate Cancer
- Hormone-Related Cancer and Autoimmune Diseases: A Complex Interplay to be Discovered
- Unraveling the Role of EV-Derived miR-150-5p in Prostate Cancer Metastasis and Its Association with High-Grade Gleason Scores: Implications for Diagnosis
- Transcriptome-Wide Analysis of Low-Concentration Exposure to Bisphenol A, S, and F in Prostate Cancer Cells
- New Approaches in Oncology for Repositioning Drugs: The Case of PDE5 Inhibitor Sildenafil
- Aptamers as Theragnostic Tools in Prostate Cancer
- Hormone-Related Cancer and Autoimmune Diseases: A Complex Interplay to be Discovered
- Inhibition of Stearoyl-CoA Desaturase by Sterculic Oil Reduces Proliferation and Induces Apoptosis in Prostate Cancer Cell Lines
- Aptamers as Theragnostic Tools in Prostate Cancer
- The role of platelets in cancer: from their influence on tumor progression to their potential use in liquid biopsy
- Unraveling the Role of EV-Derived miR-150-5p in Prostate Cancer Metastasis and Its Association with High-Grade Gleason Scores: Implications for Diagnosis
- Transcriptome-Wide Analysis of Low-Concentration Exposure to Bisphenol A, S, and F in Prostate Cancer Cells
- Aptamers as Theragnostic Tools in Prostate Cancer
- The role of platelets in cancer: from their influence on tumor progression to their potential use in liquid biopsy
- Unraveling the Role of EV-Derived miR-150-5p in Prostate Cancer Metastasis and Its Association with High-Grade Gleason Scores: Implications for Diagnosis
- Transcriptome-Wide Analysis of Low-Concentration Exposure to Bisphenol A, S, and F in Prostate Cancer Cells
- Transporters, <b><i>TBC1D4</i></b>, and <b><i>ARID5B</i></b> Variants to Explain Glycated Hemoglobin Variability in Patients with Type 2 Diabetes
- COVID-19 relevant genetic variants confirmed in an admixed population
- Supplementary Material for: Transporters, <b><i>TBC1D4</i></b>, and <b><i>ARID5B</i></b> Variants to Explain Glycated Hemoglobin Variability in Patients with Type 2 Diabetes
- New Approaches in Oncology for Repositioning Drugs: The Case of PDE5 Inhibitor Sildenafil
- Aptamers as Theragnostic Tools in Prostate Cancer
- Transporters, <b><i>TBC1D4</i></b>, and <b><i>ARID5B</i></b> Variants to Explain Glycated Hemoglobin Variability in Patients with Type 2 Diabetes
- Supplementary Material for: Transporters, <b><i>TBC1D4</i></b>, and <b><i>ARID5B</i></b> Variants to Explain Glycated Hemoglobin Variability in Patients with Type 2 Diabetes
- Transporters, <b><i>TBC1D4</i></b>, and <b><i>ARID5B</i></b> Variants to Explain Glycated Hemoglobin Variability in Patients with Type 2 Diabetes
- Supplementary Material for: Transporters, <b><i>TBC1D4</i></b>, and <b><i>ARID5B</i></b> Variants to Explain Glycated Hemoglobin Variability in Patients with Type 2 Diabetes
- Transporters, <b><i>TBC1D4</i></b>, and <b><i>ARID5B</i></b> Variants to Explain Glycated Hemoglobin Variability in Patients with Type 2 Diabetes
- Supplementary Material for: Transporters, <b><i>TBC1D4</i></b>, and <b><i>ARID5B</i></b> Variants to Explain Glycated Hemoglobin Variability in Patients with Type 2 Diabetes
- Transporters, <b><i>TBC1D4</i></b>, and <b><i>ARID5B</i></b> Variants to Explain Glycated Hemoglobin Variability in Patients with Type 2 Diabetes
- Supplementary Material for: Transporters, <b><i>TBC1D4</i></b>, and <b><i>ARID5B</i></b> Variants to Explain Glycated Hemoglobin Variability in Patients with Type 2 Diabetes
- Transporters, <b><i>TBC1D4</i></b>, and <b><i>ARID5B</i></b> Variants to Explain Glycated Hemoglobin Variability in Patients with Type 2 Diabetes
- Supplementary Material for: Transporters, <b><i>TBC1D4</i></b>, and <b><i>ARID5B</i></b> Variants to Explain Glycated Hemoglobin Variability in Patients with Type 2 Diabetes
Similar Researchers
Based on overlapping research topics